| NOVARTIS NAM. SF 0,50 |
| ISIN | CH0012005267 |
| Security | NOVN |
| Exchange | EUREX |
| Type | Option |
Options
| Exp. date | Type | Type |
|---|---|---|
| 12/19 | 70 Calls | 69 Puts |
| 1/20 | 32 Calls | 32 Puts |
| 2/20 | 32 Calls | 32 Puts |
| 3/20 | 31 Calls | 30 Puts |
| 6/20 | 40 Calls | 40 Puts |
| 9/20 | 11 Calls | 11 Puts |
| 12/20 | 40 Calls | 40 Puts |
| 6/21 | 22 Calls | 22 Puts |
| 12/21 | 22 Calls | 22 Puts |
| 6/22 | 8 Calls | 8 Puts |
| 12/22 | 19 Calls | 19 Puts |
| 12/23 | 18 Calls | 18 Puts |
Calls
| Strike | Last | Open Interest |
|---|
News
- Novartis nears deal to acquire Medicines - report
11/23/2019 / 20:54 - TeleTrader - Novartis' net sales up 10% to $12.17B in Q3
10/22/2019 / 07:03 - TeleTrader - ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/25/2019 / 17:20 - GlobeNewswire - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG
09/23/2019 / 16:23 - GlobeNewswire - ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/18/2019 / 17:40 - GlobeNewswire
Real-time